Avella Specialty Pharmacy Again Named One of Inc. 5000’s Fastest Growing Companies
Avella Specialty Pharmacy has once again been designated one of Inc. Magazine’s 5,000 fastest growing companies in America.
Phoenix, AZ -- Avella Specialty Pharmacy has once again been designated one of Inc. Magazine’s 5,000 fastest growing companies in America. Avella has received this honor each of the last 11 years, validating the company’s remarkable growth over the past decade.
This year, Avella reached number 2,680 on the Inc. 5000, based on the organization’s 3-year growth rate of 129 percent. As an 11th time honoree, Avella has joined a distinguished group of companies referred to as the “10X” club by Inc. Magazine. Only .1 percent of organizations ever ranked by the magazine have achieved this milestone. This added distinction puts Avella among a select group of companies that have not only reached incredible growth, but have also been able to sustain it over a decade or more. Avella was also the only Arizona-based company with revenue over $1B to be named to the Inc. 5000 list this year.
“Avella’s industry presence continues to expand as we penetrate new markets and develop new capabilities to better serve stakeholders across the healthcare industry. Yet we retain our core commitment to optimizing patient health as we collaborate with these partners across the care continuum,” said Rebecca M. Shanahan, CEO. “It is an honor to receive this recognition again and we are proud to be in the company of prestigious organizations in a wide array of industries.”
Inc. identified companies for this year’s list by measuring growth from 2013 to 2016. To qualify for inclusion on the list, companies must be U.S.-based, privately held, for-profit and independent (that is, not subsidiaries or divisions of other companies) as of Dec. 31, 2016. For complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, visit inc.com/profile/avella-specialty-pharmacy.